Xue Guo

F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis

Y. Nie, Haoming Xu, Yongjian Zhou, 2021, AMB Express.

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Jiaqi Wang, Y. Nie, Le Liu, 2022, Frontiers in Nutrition.

Selection strategy of dextran sulfate sodium-induced acute or chronic colitis mouse models based on gut microbial profile

Y. Nie, Huiting Chen, Hongli Huang, 2021, BMC microbiology.

Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy

Huiting Chen, Youlian Zhou, Xue Guo, 2023, Frontiers in Endocrinology.

Rapamycin extenuates experimental colitis by modulating the gut microbiota

Jiaqi Wang, Haoming Xu, Youlian Zhou, 2023, Journal of gastroenterology and hepatology.

Pretreatment with an antibiotics cocktail enhances the protective effect of probiotics by regulating SCFA metabolism and Th1/Th2/Th17 cell immune responses

Jiaqi Wang, Yingfei Li, Hongli Huang, 2024, BMC microbiology.